reports
- Olfa Taamallah
- Yan Derocles
Wizz Air : Reassuring trading update for FY 2024
>FY 2024 pretty much in line with expectations - Wizz Air has just released an unaudited post-close trading update for the FY to end-March 2024. Net income is expected in the range of € 350 - 370m for FY, in line with guidance. We were expecting € 357m and the Visible Alpha consensus €352m. Total revenue is expected to be in the range of € 5,050 - 5,100m (ODDO BHF: € 5,165m, VA € 5,154m) reflecting stronger ticket revenue and pricing, partially offset by softer ...
- Geoffroy Michalet
Bureau Veritas : A very solid Q1– Guidance confirmed
>Q1 revenues higher than expected - Revenues amounted to € 1,440m, which is 2.5% higher than in Q1 2023. We had expected € 1,474m (4.9%e, due to a forex error) and the consensus € 1,435m (1.4%). Organic growth reached 8.0%, above our forecast (5.9%) and that of the consensus (6.5%). The FX impact came to -5.6% (ODDO BHF -1.0%e, consensus -5.0%). Overall, the momentum was very robust in all the group’s divisions, exceeding our expectations with: Single-digit...
- Geoffroy Michalet
Casino : Post-restructuring Q1 results, satisfactory sales, still very...
>Satisfactory sales but margins and FCF are too low - Casino reported Q1 sales of € 2.1bn, down 4.6% of which -3.8% LFL. The key standouts to us were the respectable performances of Monoprix (+0.7% LFL) and Franprix (+0.6% LFL). These figures were not so bad in light of Carrefour’s performance (+0.2% LFL for convenience brands this quarter). Stores under the Casino banner were down 2.4%, bringing the overall convenience brand performance to +0.1%.On the other han...
- Damien Choplain
- Martial Descoutures
AstraZeneca : Very reassuring Q1 supports 2024 targets
>Symbicort and Farxiga lead the way - AZN has reported much stronger than expected Q1 2024 results, mainly thanks to Farxiga and Symbicort. Revenue increased by 19% at constant exchange rates, boosted by CVRM (cardio and metabolism) and Oncology. Sales came out 7% higher than expected. Although penalised by a recent reduction in prices for Tagrisso (June 23), Imfinzi (February 24) and Faslodex in China (November 23), revenue in China increased by 13%. However, th...
- Christophe-Raphaël Ganet
Interparfums : 2024 Q1 sales flat due to base effects, estimates uncha...
>Q1 2024 revenues flat cc - Q1 sales came in at € 212.7m, i.e. -1% and +0% cc, slightly below our expectations.Montblanc and Jimmy Choo (46% of sales) were down by 6% and 24% respectively, while Coach (22% of sales) shows a slight increase (+3%). Other brands were down.The South America, Asia, France and western Europe regions (i.e. 55% of sales) were up, the others (North America, eastern Europe, Africa, Middle East) were down.The growth delivered is ...
- Geoffroy Michalet
SMCP : Q1 revenue below forecasts - Operational challenges remain the ...
>Commercial momentum less favourable in France and China - SMCP has reported Q1 sales of € 287m, down -5.8%, on reported terms of which -5.0% organic, below our forecast (-1.4e%) By geographic region: France (33% of sales): down -7.4% lower organic than expected (-5.0%e) impacted by a tough comparison base with relatively unfavourable commercial momentum in line with Q4 2023 (-6.7% organic) EMEA (32% of sales) stable at +0.1% on an organic basis, bett...
- Ahmed Ben Salem
- Thijs Berkelder
Aker BP : Q1 results beat expectations, pressure on cash and few catal...
>Operating profit 4% higher than expected - Aker BP released its Q1 2024 results showing revenues fully in line with expectations but EBITDA and EBIT 4% higher than expected at $ 2.8bn (-17.7% q-o-q) and € 2.2bn (+1.9% q-o-q), respectively. Net profit was 13% higher than expected at $ 531m, boosted by a tax rate of 75% vs 92% in Q4. CFFO was virtually flat at $ 1.45bn and FCF was down -26% to $ 339m.Good operating performance but upcoming maintenance st...
- Olfa Taamallah
- Yan Derocles
Wizz Air : Reassuring trading update for FY 2024
>FY 2024 pretty much in line with expectations - Wizz Air has just released an unaudited post-close trading update for the FY to end-March 2024. Net income is expected in the range of € 350 - 370m for FY, in line with guidance. We were expecting € 357m and the Visible Alpha consensus €352m. Total revenue is expected to be in the range of € 5,050 - 5,100m (ODDO BHF: € 5,165m, VA € 5,154m) reflecting stronger ticket revenue and pricing, partially offset by softer ...
- Geoffroy Michalet
Carrefour : Decent Q1 sales, price adjustment policy in France funded ...
>Q1 2024: in line with forecasts - Yesterday evening, Carrefour published its sales figures for Q1 2024. Sales including tax were € 22.2bn, a slight 0.4% increase on a reported basis of which 13.5% l-f-l, broadly in line with expectations in France, relatively weak in Europe and a shade above in Latin America. Overall, as expected, the quarter was marked by the continued deceleration in food inflation and a volume effect still under pressure in Europe, to which sho...
- Damien Choplain
- Martial Descoutures
Sanofi : Q1 2024 passes without a hitch
>A little better than expected - Sanofi has reported this morning Q1 2024 results a little above forecasts at the level of sales and EPS. As expected, Sanofi suffered from a deeply negative forex effect (-4.3% on the topline and -10.2% on the bottom line).In short, total group sales came to € 10.464 bn vs € 10.272 bn (+2.4%; +6.7% at cc), core EBIT to € 2.843 bn vs € 2.748 bn est. (-14.7%; -4.2% at cc) and core EPS to € 1.78 vs € 1.71 est., down 7.4% at cc (sour...
- Geoffroy Michalet
Bureau Veritas : Publication T1 très solide– Guidance confirmée
>CA T1 supérieur aux attentes - Le CA est ressorti à 1 440 M€, soit une hausse de 2.5% par rapport au T1 2023. Là où nous attendions 1 474 M€ (4.9%e, à cause d’une erreur sur le FX) et le consensus 1 435 M€ (1.4%). La croissance organique ressort à 8.0% supérieure à nos attentes (5.9%) et celles du consensus (6.5%). Le FX ressort à -5.6% (ODDO BHF -1.0%e, css -5.0%). Dans l’ensemble, la dynamique est de très bonne facture à travers les divisions. Elle est ressor...
- Delphine Brault
- Quentin Borie
Metso : Reassuring Q1 orders but results are below expectations
>Q1 2024: orders down -6%, sales down -7%, adjusted EBITA margin of 16.5% - Metso this morning reported Q1 2024 results that were 7% below expectations at adjusted EBITA level. Order intake was € 1,361m (consensus € 1,361), down -6% on an organic basis (consensus -5.8%). Orders were up sequentially in both divisions with improved market activity in Aggregates (driven by the US) and in Minerals (Services). Sales were down -7% (consensus -2.4%) on an organic b...
- Delphine Brault
- Quentin Borie
Metso : Reassuring Q1 orders but results are below expectations
>Q1 2024: orders down -6%, sales down -7%, adjusted EBITA margin of 16.5% - Metso this morning reported Q1 2024 results that were 7% below expectations at adjusted EBITA level. Order intake was € 1,361m (consensus € 1,361), down -6% on an organic basis (consensus -5.8%). Orders were up sequentially in both divisions with improved market activity in Aggregates (driven by the US) and in Minerals (Services). Sales were down -7% (consensus -2.4%) on an organic b...
- Geoffroy Michalet
SMCP : CA T1 en dessous de nos attentes - Les enjeux opérationnels res...
>Dynamique commerciale dépréciée en France et en Chine - Au titre de son T1, SMCP publie un CA de 287 M€, en recul de 5.8% en données publiées dont -5.0% en organique, inférieur à notre attente (-1.4e%). Par zone géographique : France (33% du CA) : en baisse de 7.4% en organique plus faible qu’attendu (-5.0%e) impactée par une base de comparaison difficile avec une dynamique commerciale peu favorable dans la lignée du T4 2023 (-6.7% en organique). §rc...
- Ahmed Ben Salem
Repsol : Q1 2024 results beat expectations by 6.4% with higher gearing...
>Adjusted net profit 6.4% above expectations supported by strong refining - Q1 2024 adjusted net profit came in at € 1,267 m (6% q-o-q/-33% y-o-y), 18% above our estimates and 6.5% above the consensus (ODDO BHF: € 1,067m; consensus: € 1,191m).Upstream: Q1 2024 adjusted net income came in at € 442m, well above estimates (ODDO BHF: € 339m; consensus: € 368m) with flat production at 590 kboe/d supported by lower royalties and a regularisation on the tax estimate fro...
- Ahmed Ben Salem
Repsol : Q1 2024 results beat expectations by 6.4% with higher gearing...
>Adjusted net profit 6.4% above expectations supported by strong refining - Q1 2024 adjusted net profit came in at € 1,267 m (6% q-o-q/-33% y-o-y), 18% above our estimates and 6.5% above the consensus (ODDO BHF: € 1,067m; consensus: € 1,191m).Upstream: Q1 2024 adjusted net income came in at € 442m, well above estimates (ODDO BHF: € 339m; consensus: € 368m) with flat production at 590 kboe/d supported by lower royalties and a regularisation on the tax estimate fro...
- Martial Descoutures
- Oussema Denguir
Adocia : 2024, a potentially transforming year for Adocia
>Operational cash burn down significantly - Yesterday evening, Adocia published its FY 2023 figures. Operating profit over the period was € 6m (vs € 17.3m in 2022, including a milestone payment of € 4.8m received as part of its partnership agreement in China). Underlying operating charges were down 31% to € 20.3m, driven by the reduction in R&D charges to € 14.8m (vs € 25.9m in 2022). This resulted in an operating loss of -€ 14.2m (vs -€ 12.9m previously).The cas...
- Damien Choplain
- Martial Descoutures
AstraZeneca : Un T1 extrêmement rassurant confirmant les ambitions 202...
>Symbicort et Farxiga mènent la danse - AZN vient de publier ses résultats du T1 24 qui se révèlent nettement supérieurs aux attentes du fait notamment de Farxiga et Symbicort. Les revenus sont en hausse de 19% à tcc tirés par sa franchise CVRM (cardio metabolique) et Oncologie. Les ventes ressortent ainsi 7% au-dessus des attentes. Bien que pénalisée par une baisse de prix récentes de Tagrisso (Juin 23), Imfinzi (Fevr 24) et Faslodex en Chine (Nov 23), la Chine est e...
- Martial Descoutures
- Oussema Denguir
Cosmo Pharmaceuticals : Change of management
>Giovanni Di Napoli to be group CEO - Cosmo Pharmaceuticals this morning announced the appointment of Giovanni Di Napoli as CEO, to replace Alessandro Della Chà. The appointment takes effect at the AGM scheduled for 24 May. This appointment follows the Capital Market Day in March which set out the next stages for the company and its ambitions. Mr Di Napoli is very familiar with the GI Genius platform, coming from Medtronic where he occupied several management pos...
- Delphine Brault
- Quentin Borie
Atlas Copco : Very good start to the year, positive signs for semicond...
>Q1 2024: order intake beat expectations by 9% - Yesterday Atlas Copco reported Q1 2024 results (see table page 2).Order intake was down 4% LFL yoy (consensus -12.7%) but beat the consensus by 9% (Compressor Technique -1% LFL vs the consensus estimate of -12.9%).Organic revenue growth reached 7% (consensus: 5.6%) of which 8% for Compressor Technique, 9% for Power Technique, and 19% for Industrial Technique, with volumes that we estimate were up in all divis...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.